A commitment to global collaboration, welcoming international participation and advancing science for the benefit of patients

Pantep Angchaisuksiri; Wolfram Ruf; Jeffrey Weitz; Sam Schulman; Guy A. Young; Bianca Rocca; Emma C. Hansson; Milan Milojevic; Anders Jeppsson

doi:10.4081/btvb.2025.188

Search

Search articles for

Advanced filters

Published AfterYearMonthDay

Published BeforeYearMonthDay

By Author

By Section

Search Results

##search.searchResults.foundPlural##

Combined oral contraceptives and the risk of venous thromboembolism carriers of antithrombin, protein C or S deficiency: Sub-analysis of a prospective cohort study

Daniela Tormene, Elena Campello, Chiara Simion, Anna Poretto, Paolo Prandoni, Paolo Simioni

03-11-2022

https://doi.org/10.4081/btvb.2022.42

844

PDF: 278
Distal deep vein thrombosis: is there a way out of this dark forest?

Matteo Guarascio, Gerardo Nicola Pititto, Alessia Abenante, Marco Paolo Donadini

04-09-2024

https://doi.org/10.4081/btvb.2024.129

676

PDF: 213
Rationale and design of a study on D-dimer use to stratify patients after a first unprovoked venous thromboembolism for their risk of recurrence: extended low-dose Apixaban given only to patients with positive D-dimer results The Apidulcis study

Gualtiero Palareti, Paolo Prandoni, Cristina Legnani, Emilia Antonucci, Serena Zorzi, Alberto Tosetto, Lorenza Bertù, Sophie Testa, Vittorio Pengo, Walter Ageno, Ida Martinelli, Benilde Cosmi, Eugenio Bucherini, Daniela Poli

22-03-2022

https://doi.org/10.4081/btvb.2022.10

1031

PDF: 326

APPENDIX: 66
Association between non-O blood type and early unexplained recurrent spontaneous abortion in women with and without inherited thrombophilia

Anna Poretto, Elisabetta Borella, Giacomo Turatti, Michelangelo Marobin, Elena Campello, Daniela Tormene, Paolo Simioni, Luca Spiezia

14-11-2022

https://doi.org/10.4081/btvb.2022.47

1144

PDF: 206
Major bleedings in mechanical prosthetic heart valves patients on Vitamin K antagonist treatment. Data from the PLECTRUM Study

Daniela Poli, Emilia Antonucci, Gualtiero Palareti, Roberto Facchinetti, Pietro Falco, Giuseppina Serricchio, Teresa Lerede, Lucilla Masciocco, Paolo Gresele, Sophie Testa

27-07-2022

https://doi.org/10.4081/btvb.2022.34

4543

PDF: 385

Supplementary Files: 111
The von Willebrand factor-ADAMTS-13 axis: a two-faced Janus in bleeding and thrombosis

Stefano Lancellotti, Monica Sacco, Maira Tardugno, Antonietta Ferretti, Raimondo De Cristofaro

26-04-2022

https://doi.org/10.4081/btvb.2022.11

1980

PDF: 343
Polycythemia vera and management of the thrombotic risk: an update

Massimo Franchini

20-12-2023

https://doi.org/10.4081/btvb.2023.102

1831

PDF: 269
Cancer-associated ischemic stroke: current knowledge and future directions

Ronda Lun, Deborah M. Siegal

16-05-2024

https://doi.org/10.4081/btvb.2024.117

1766

PDF: 449
Influence of emicizumab on protein C-mediated clotting regulation

Federica Mancazzo, Antonia Vitulli, Lavinia Dirienzo, Concetta T. Ammollo, Fabrizio Semeraro, Mario Colucci

25-10-2023

https://doi.org/10.4081/btvb.2023.89

1960

PDF: 221

Supplementary Material: 44
New perspectives for prevention of the post-thrombotic syndrome

Paolo Prandoni

22-03-2022

https://doi.org/10.4081/btvb.2022.20

1435

PDF: 438
Comparison among three different bleeding scores and the thrombin generation assay to assess the different hemorrhagic phenotypes in patients with FVII deficiency

Samantha Pasca, Cristina Santoro, Chiara Ambaglio, Marisanta Napolitano, Marta Milan, Letizia Natali, Silvia Nannizzi, Filippo Mori, Paolo Simioni, Ezio Zanon

23-05-2022

https://doi.org/10.4081/btvb.2022.12

4964

PDF: 299
It’s definitely time to consider diet in its ultra-processing form as a major risk factor for thrombotic vascular disorders

Marialaura Bonaccio, Licia Iacoviello, Maria Benedetta Donati

03-08-2023

https://doi.org/10.4081/btvb.2023.91

1090

PDF: 210
Recent advances in classic heparin-induced thrombocytopenia (HIT), autoimmune HIT, spontaneous HIT, and vaccine-induced immune thrombotic thrombocytopenia

Bianca Clerici, Mariangela Scavone, Gian Marco Podda

20-06-2024

https://doi.org/10.4081/btvb.2024.127

1859

PDF: 497
Identifying novel biomarkers using proteomics to predict cancer-associated thrombosis

Maria J. Fernandez Turizo, Rushad Patell, Jeffrey I. Zwicker

16-05-2024

https://doi.org/10.4081/btvb.2024.120

709

PDF: 306
Venous thromboembolism treatment in patients with cancer: reflections on an evolving landscape

Agnes Y.Y. Lee

29-02-2024

https://doi.org/10.4081/btvb.2024.111

1437

PDF: 305
Safety of COVID-19 mRNA vaccination in patients with history of acquired hemophilia A: a case series

Luca Puccetti, Vincenzo Sammartano, Federico Caroni, Margherita Malchiodi, Paola Calzoni, Eleonora Franceschini, Lucrezia Galasso, Monica Bocchia

17-10-2022

https://doi.org/10.4081/btvb.2022.40

2380

PDF: 222
The evolving landscape of gene therapy for congenital severe hemophilia: a 2024 state of the art

Giovanni Di Minno, Gaia Spadarella, Ilenia Lorenza Calcaterra, Giancarlo Castaman, Paolo Simioni, Raimondo De Cristofaro, Cristina Santoro, Flora Peyvandi, Matteo Di Minno

04-09-2024

https://doi.org/10.4081/btvb.2024.144

835

PDF: 190

SUPPLEMENTARY MATERIAL: 89

1 - 17 of 17 items

Search

Search Results

Combined oral contraceptives and the risk of venous thromboembolism carriers of antithrombin, protein C or S deficiency: Sub-analysis of a prospective cohort study

Distal deep vein thrombosis: is there a way out of this dark forest?

Rationale and design of a study on D-dimer use to stratify patients after a first unprovoked venous thromboembolism for their risk of recurrence: extended low-dose Apixaban given only to patients with positive D-dimer results The Apidulcis study

Association between non-O blood type and early unexplained recurrent spontaneous abortion in women with and without inherited thrombophilia

Major bleedings in mechanical prosthetic heart valves patients on Vitamin K antagonist treatment. Data from the PLECTRUM Study

The von Willebrand factor-ADAMTS-13 axis: a two-faced Janus in bleeding and thrombosis

Polycythemia vera and management of the thrombotic risk: an update

Cancer-associated ischemic stroke: current knowledge and future directions

Influence of emicizumab on protein C-mediated clotting regulation

New perspectives for prevention of the post-thrombotic syndrome

Comparison among three different bleeding scores and the thrombin generation assay to assess the different hemorrhagic phenotypes in patients with FVII deficiency

It’s definitely time to consider diet in its ultra-processing form as a major risk factor for thrombotic vascular disorders

Recent advances in classic heparin-induced thrombocytopenia (HIT), autoimmune HIT, spontaneous HIT, and vaccine-induced immune thrombotic thrombocytopenia

Identifying novel biomarkers using proteomics to predict cancer-associated thrombosis

Venous thromboembolism treatment in patients with cancer: reflections on an evolving landscape

Safety of COVID-19 mRNA vaccination in patients with history of acquired hemophilia A: a case series

The evolving landscape of gene therapy for congenital severe hemophilia: a 2024 state of the art

authors

reviewers

Categories

indexing

aice

Keywords